FOXP3 and neoplasm: Interestingly, declining FOXP3 mRNA levels correlated with advancing tumor stages, and stage-stratified survival analysis confirmed that low FOXP3 expression in advanced stages was significantly associated with poor overall survival in both the MMA and TCGA cohorts.